KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.5379
+0.0306 (6.03%)
At close: Sep 8, 2026, 4:00 PM EDT
0.5210
+0.0137 (2.70%)
Pre-market: Sep 9, 2026, 6:47 AM EDT
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$1,680,000
Market Cap
10.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -32 | -84.21% |
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Vistagen Therapeutics | 41 |
| Senti Biosciences Holdings | 39 |
| Lunai Bioworks | 29 |
| Imunon | 20 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Aprea Therapeutics | 8 |
KALA News
- 5 days ago - Kala Bio, Virotek announce exclusive distribution and reseller agreement - TheFly
- 5 days ago - Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program - GlobeNewsWire
- 7 days ago - Kala Bio, Virotek enters LOI for distribution agreement - TheFly
- 7 days ago - Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program - GlobeNewsWire
- 21 days ago - KALA BIO Quarterly report: Q2 2026 - Filings
- 2 months ago - KALA BIO Registration statement: Registration filing - Filings
- 3 months ago - KALA BIO Quarterly report: Q1 2026 - Filings
- 3 months ago - Kala Bio falls -21.7% - TheFly